XORTX Therapeutics
Price & Volume
Stats
See more52W Range | $0.37-$1.41 |
Market Cap | $2.7M |
Shares Short | 2,008 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.40 |
News
See moreYahoo Finance • 21 days ago
XORTX Provides Update on Acquisition of Renal Anti-Fibrotic Therapeutic Program from Vectus Biosystems
Yahoo Finance • 2 months ago
XORTX Announces Pioneering Research on Genome-Wide Pathogenic Pathways in Gout and Provides a Corporate Update
Yahoo Finance • 4 months ago
XORTX Announces Pricing of US$1.1 Million Registered Direct Offering
About
CEO | Dr. Allen Warren Davidoff Ph.D. |
Address | 3710 ? 33rd Street NW, Calgary, AB, Canada, T2L 2M1 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 0 |
